Background:
• Afghanistan
• Airplane and Airport Security
• Osama bin Laden / Al-Qaida
• Financial Markets
• Hate Crimes

• Homeland Defense
• Military Service
• Military Tribunals
• Terrorism

Terrorism

Congress:
• 9/11 Report: Joint Congressional Inquiry (July 24, 2003)
• View from the Hill: Congressional Efforts to Address Bioterrorism By S. Anthony McCann, Staff Director, House Appropriations Subcommittee. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
  
  The White House:
• Memorandum of Understanding (PDF) (Re: Merger of Federal Anti-Terror Watch Lists) (Signed by heads of Departments of State, Justice, Homeland Security, and CIA,) (Sep. 16, 2003)
• Executive Order 13099: Prohibiting Transactions With Terrorists Who Threaten to Disrupt the Middle East Peace Process (PDF) Added Usama bin Ladin and Al-Qaida to terrorist list. From President William J. Clinton. Aug 20, 1998
• Executive Order 13129: Blocking Property and Prohibiting Transactions With the Taliban (PDF) Jul 4, 1999
• U.S. Policy on Counterterrorism From President WIlliam J. Clinton. Jun 21, 1995
  
  Al Qaeda:
• Training Manual: Cover - Lesson 4
• Training Manual: Lesson 5 - Lesson 8
• Training Manual: Lesson 9 - Lesson 11
• Training Manual: Lesson 12 - End
  
  Saudi Arabia Embassy Information Office's Report On Terrorism:
• Report (PDF) Dec. 2, 2002
  
  American Medical Association:
• Anthrax as a Biological Weapon From the Journal of the American Medical Association, Vol. 281, No. 18. May 12, 1999
  
  United States Army:
• Assymmetric Warfare: Is the Army Ready? Analyzes asymmetric warfare to see how it affects the United States Army, whether the Army is doing or can do anything about it, and, finally, whether the Army is ready for a "new" old threat - asymmetric warfare. By Robert H. Allen, Army Management Staff College.
• Commentary: The Asymmetric Threat Discusses how current Army doctrine fails to address the asymmetric threat to at-risk, high-value logisticts assets. By Cadet First Class Michael L. Kolodzie, USMA. From Army Logistician, Jul - Aug 2001
• Back to the Future with Asymmetric Warfare By Vincent J. Goulding, Jr. From Parameters, US Army War Quarterly, Winter 2000-01.
• Clinical and Epidemiologic Principles of Anthrax By Theodore J. Cieslak and Edwared M. Eitzen, Jr., U.S. Army Medical Research Institute of Infectious Diseases. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
• Epidemiology of Bioterrorism By Julie A. Pavlin, Walter Reed Army Institute of Research. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
• Potential Biological Weapons Threats By Mark G. Kortepete and Gerald W. Parker, U.S. Army Medical Research Institute of Infectious Diseases. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
  
  The Brookings Institution:
• Beyond Missile Defense: Countering Terrorism and Weapons of Mass Destruction Discusses missile defense and other programs for countering weapons of mass destruction and terrorism. By Michael E. O'Hanlon. Aug 2001
• Terrorism Goes Global: Extremist Groups Extend Their Reach Worldwide By Paul R. Pillar. From the Brookings Review, Fall 2001, Vol. 19, No. 4.
  
  State of California:
• California Hospital Bioterrorism Response Planning Guide (PDF) From the California Department of Health Services. Includes a bioterrorism response overview and prevention recommendations for isolation precautions. Oct 5, 2001
  
  Centers for Disease Control and Prevention:
• Anthrax Features FAQs on anthrax.
• Notice to Readers: Considerations for Distinguishing Influenza-Like Illness from Inhalational Anthrax From Morbidity and Mortality Weekly Report, Vol. 50, No. 44. Nov 9, 2001.
• Update: Adverse Events Associated with Anthrax Prophylaxis Among Postal Employees --- New Jersey, New York City, and the District of Columbia Metropolitan Area, 2001 From Morbidity and Mortality Weekly Report, Vol. 50, No. 47. Nov 30, 2001.
• Update: Investigation of Bioterrorism-Related Anthrax and Adverse Events from Antimicrobial Prophylaxis From Morbidity and Mortality Weekly Report, Vol. 50, No. 44. Nov 9, 2001.
• Update: Investigation of Anthrax Associated with Intentional Exposure and Interim Public Health Guidelines, October 2001 From Morbidity and Mortality Weekly Report, Vol. 50, No. 47. Oct 19, 2001.
• Combating Terrorism: Management of Medical Stockpiles Testimony by Stephen M. Ostroff, M.D., Associate Director for Epidemiologic Science, National Center for Infectious Diseases. Mar 8, 2000
• Medical Responses to Terrorist Attacks Statement by Scott R. Lillibridge, M.D., National Center for Infectious Diseases. Sep 22, 1999
• Threat of Bioterrorism in America: Assessing the Adequacy of Federal Law Relating to Dangerous Biological Agents Testimony by Stephen M. Ostroff, M.D., Associate Director for Epidemiologic Science, National Center for Infectious Diseases. May 20, 1999
• Bioterrorism Statement by James M. Hughes, M.D., Director, National Center for Infectious Diseases. Discusses bioterrorism and the public health response. Apr 20, 1999
• Preparedness for Epidemics and Bioterrorism Testimony by James M. Hughes, M.D., Director, National Center for Infectious Diseases. Discusses the public health response to disease outbreaks caused by biological and chemical terrorism. Jun 2, 1998
• The Emerging Threat of Bioterrorism By James M. Hughes. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
• Bioterrorism Alleging Use of Anthrax and Interim Guidlines for Management From Morbidity and Mortality Weekly Report. Feb 5, 1999
• The Economic Impact of a Bioterrorist Attack: Are Prevention and Postattack Intervention Programs Justifiable? By Arnold F. Kaufmann, Martin I. Meltzer and George P. Schmid. From Emerging Infectious Diseases, Vol. 3, No. 2. Apr - Jun 1997.
  
  Center for Strategic and International Studies:
• Islamic Extremism in Saudi Arabia and the Attack on Al Khobar By Anthony H. Cordesman, Arleigh A. Burke Chair in Strategy. (PDF) Jun 2001
• The Changing Face of Terrorism and Technology, and the Challenge of Asymmetric Warfare By Anthony H. Cordesman, Arleigh A. Burke Chair in Strategy. Mar 27, 2001
• The Risks and Effects of Indirect, Covert, Terrorist, and Extremist Attacks with Weapons of Mass Destruction By Anthony H. Cordesman, Senior Fellow for Strategic Assessment. Feb 14, 2001
• Homeland Defense: The Current and Future Terrorist Threat Sep 1, 2000
  
  Central Intelligence Agency (CIA):
• International Terrorism: Challenge and Response Speech by Deputy Chief, DCI Counterterrorist Center, to World Affairs Council. Nov 16, 1998
• International Terrorism in 1997: A Statistical View Mar 1998
• A Survey of Threats and Challenges to the United States Speech by John L. Helgerson, Director of Russian and European Analysis, to the Military Order of the World Wars. Jan 16, 1998
• The International Terrorist Threat to US Interests Speech by Senior Analytical Manager, DCI Counterterrorist Center, to the World Affairs Council. Oct 7, 1996
• Fighting Foreign Terrorism Speech by John Deutsch, Director of Central Intelligence. Sep 5, 1996
  
  Clinical Infectious Diseases:
• The Malevolent Use of Microbes and the Rule of Law: Legal Challenges Presented by Bioterrorism By David P. Fidler, Professor, Indiana University School of Law. Jul 30, 2001
  
  Congressional Research Service:
• Terrorism, the Future, and U.S. Foreign Policy (PDF) By Raphael F. Perl, Foreign Affairs, Defense, and Trade Division. Sep 12, 2001
• Terrorism: Near Eastern Groups and State Sponsors, 2001 (PDF) By Kenneth Katzman, Specialist in Middle Eastern Affairs, Foreign Affairs, Defense, and Trade Division. Sep 10, 2001
• Terrorism: Automated Lookout Systems and Border Security Options and Issues (PDF) By William J. Krouse, Analyst in Social Legislation, Domestic Social Policy Division, and Raphael F. Perl, Specialist in International Affairs, Foreign Affairs, Defense, and Trade Division. Jun 18, 2001
• Terrorism and the Military's Role in Domestic Crisis Management: Background and Issues for Congress (PDF) By Jeffrey D. Brake, National Defense Fellow, Foreign Affairs, Defense, and Trade Division. Apr 19, 2001
• National Commission on Terrorism Report: Background and Issues for Congress (PDF) Feb 6, 2001
• Terrorist Attack on USS Cole: Background and Issues for Congress (PDF) By Raphael Perl, Specialist in International Affairs, Ronald O'Rourke, Specialist in National Defense, Foreign Affairs, Defense, and Trade Division. Jan 30, 2001
• Weapons of Mass Destruction — the Terrorist Threat (PDF) By Steve Bowman and Helit Barel, Foreign Affairs, Defense, and Trade Division. Dec 9, 1999
• Terrorism: U.S. Response to Bombings in Kenya and Tanzania: A New Policy Direction? (PDF) By Raphael F. Perl, Specialist in International Affairs, Foreign Affairs and National Defense Division. Sep 1, 1998
  
  Council on Foreign Relations:
• The Prospect of Domestic Bioterrorism By Jessica Stern, Fellow. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
  
  Department of Agriculture:
• Anthrax From the Animal and Plant Health Inspection Service.
• Anthrax From the Animal and Plant Health Inspection Service. Covers epidemiology, clinical signs, diagnosis, human health risk and more. Sep 1999
  
  Department of Defense:
• The Risks If We Would Be Free Argues that withdrawing our military forces or withdrawing from our daily lives or our commerce when attacked by terrorists is the worst thing we could do. Remarks by Secretary of Defense William J. Perry to the American Bar Association. Aug 6, 1996
  
  Department of Health and Human Services:
• HHS Initiatives Prepares for Possible Bioterrorism Threats Aug 16, 2001
• HHS Initiatives Prepares for Possible Bioterrorism Threats May 18, 2000
• Addressing Bioterrorist Threats: Where Do We Go From Here? By Margaret A. Hamburg, Assistant Secretary for Planning and Evaluation. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
• Bioterrorism: How Prepared Are We? By Donna E. Shalala, U.S. Secretary of Health and Human Services. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
• Bioterrorism Testimony by William Clark, Deputy Director, Office of Emergency Prepardness. Mar 25, 1999
• Bioterrorism Testimony by Margaret A. Hamburg, M.D., Assistant Secretary for Planning and Evaluation. Mar 16, 1999
• Anti-Terrorism Measures By Robert F. Knouss, M.D., Director, Office of Emergency Preparedness. Oct 2, 1998
  
  Department of Justice:
• Assessment of the Increased Risk of Terrorist or other Criminal Activity Associated with Posting Off-Site Consequence Analysis Information on the Internet (PDF) Apr 18, 2000
  
  Department of State:
• Country Reports on Terrorism 2006
• Country Reports on Terrorism 2005
• Country Reports on Terrorism 2004
• Patterns of Global Terrorism 2003 Apr 2004
• Patterns of Global Terrorism 2002 Apr 2003
• Patterns of Global Terrorism 2001 Apr 2002
• Patterns of Global Terrorism 2000 Apr 2001
• Patterns of Global Terrorism 1999 (PDF) Apr 2000
• Foreign Terrorist Organizations Oct 8, 1999
• Political Violence Against Americans: 1998 (PDF)
• Political Violence Against Americans: 1997 (PDF)
• Countering Terrorism: Security Suggestions for U.S. Business Representatives Abroad (PDF) June 1999
• Patterns of Global Terrorism 1998 Apr 1999
• Patterns of Global Terrorism 1997 Apr 1998
• Patterns of Global Terrorism 1996 Apr 1997
• Patterns of Global Terrorism 1995 Apr 1995
• Patterns of Global Terrorism 1994 Apr 1994
• Patterns of Global Terrorism 1993 Apr 1993
• Patterns of Global Terrorism 1992 Apr 1992
• Patterns of Global Terrorism 1991 Apr 1991
• Patterns of Global Terrorism 1990 Apr 1990
• Patterns of Global Terrorism 1989 Apr 1989


The Estimate: Political & Security Intelligence Analysis of the Islamic World and its Neighbors
• “Asymmetric Warfare”, The USS Cole, and the Intifada Comments on asymmetric warfare, the new intifada and the military options available to both sides, and the attack on the Cole and its implications. From Volume XII, No. 22. Nov 3, 2000
• Asymmetry Mismatch Between Israeli and Palestinian Tactics is a Classic Case of the Problems of “Asymmetric Warfare” From Volume XIII, No. 15. Aug 24, 2001
  
  Executive Agencies:
• United States Government Interagency Domestic Terrorism Concept of Operations Plan (PDF) Jan 2001
  
  Federal Bureau of Investigation:
• Congressional Statement on the Threat of Terrorism to the United States By Louis J. Freeh, Director, Federal Bureau of Investigation. May 10, 2001
• Congressional Statement on Preparedness for Terrorism Response By Barbara Y. Martinez, Deputy Director, National Domestic Preparedness Office, Federal Bureau of Investigation. Jun 9, 1999
• Threat of Bioterrorism in America Statement of Robert M. Burnham, Chief, Domestic Terrorism Section. May 20, 1999
• Terrorism in the United States 1999 (PDF)
• Congressional Statement on Foreign Terrorists in America: Five Years After the World Trade Center By Dale Watson, Chief, International Terrorism Section, National Security Division, Federal Bureau of Investigation. Feb 24, 1998
• Terrorism in the United States 1998 (PDF)
• A Report to the American People on the Work of the FBI: 1993-1998 Covers foreign terrorists in the United States, domestic terrorism and more.
• Congressional Statement on the Threat of International Organized Crime and Global Terrorism and the International Law Enforcement Programs of the Federal Bureau of Investigation By Louis J. Freeh, Director, Federal Bureau of Investigation. Oct 1, 1997
• Congressional Statement on Counterterrorism By Louis J. Freeh, Director, Federal Bureau of Investigation. May 13, 1997
• Terrorism in the United States 1997 (PDF)
• Terrorism in the United States 1996 (PDF)
  
  Federal Emergency Management Agency:
• Fact Sheet: Terrorism Covers what to do before and after a terrorist attack.
• Emergency Reponse to Terrorism Self-Study (PDF) June 1999.
• Radiological Emergency Response Independent Study (PDF) Jan 1998.
• Radiological Emergency Management Independent Study Course (PDF)
  
  Food and Drug Administration:
• CIPRO® Administrative Documents (PDF) From the Food and Drug Administration approval package for the use of CIPRO® in inhalation anthrax (post-exposure).
• CIPRO® Approval Letter (PDF) From the Food and Drug Administration to Bayer Corporation. Aug 30, 2000
• CIPRO® Clinical Pharmacology and Biopharmaceutics Review (PDF) Feb 29, 2000
• CIPRO® Correspondence (PDF) Features correspondence between the Food and Drug Administration and Bayer Corporation.
• CIPRO® Label (PDF) For CIPRO® (ciprofloxacin hydrochloride) tablets and CIPRO® (ciprofloxacin) 5% and 10% oral suspensions.
• CIPRO® Medical Review (PDF) Medical officer's review of supplemental
• CIPRO® (Ciprofloxacin Hydrochloride) for Inhalation Anthrax Information on CIPRO® for Consumers: Questions and Answers.
• CIPRO® (Ciprofloxacin Hydrochloride) for Inhalation Anthrax Message to Physicians and Health Practitioners on CIPRO®.
• CIPRO® Microbiology Review (PDF) Supplement for the addition of Anthrax (post exposure prophylaxis) as an approved indication.
• CIPRO® Pharmacology Review (PDF) Review and evaluation of pharmacology and toxicology data.
• CIPRO® Statistical Review (PDF) Statistical review and evaluation on the efficacy of ciprofloxacin as a post exposure prophylaxis for inhalational anthrax. Aug 16, 2000
• Transcript of a Meeting of the Anti-Infective Drugs Advisory Committee. (RTF) Includes testimony on anthrax clinical disease and epidemiology, human pathology inhalational disease, and non-human primate model of inhalational anthrax. Also available in PDF: Part 1, Part 2, and Part 3. Jul 28, 2000
• Anthrax Information on the anthrax vaccine.
• Vaccines, Pharmaceutical Products, and Bioterrorism: Challenges for the U.S. Food and Drug Administration By Kathryn C. Zoon, Director, Center for Biologics Evaluation and Research (CBER). From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
  
  Federal Research Division:
• The Sociology and Psychology of Terrorism: Who Becomes a Terrorist and Why? Report Prepared under an Interagency Agreement by the Federal Research Division, Library of Congress, September 1999.
  
  General Accounting Office (GAO):
• Anti-Money Laundering: Efforts in the Securities Industry (PDF) Oct 10, 2001
• Terrorism Insurance: Alternative Programs for Protecting Insurance Consumers (PDF) Statement of Richard J. Hillman, Director, Financial Markets and Community Investment. Oct 24, 2001
• Terrorism Insurance: Alternative Programs for Protecting Insurance Consumers (PDF) Statement of Thomas J. McCool, Managing Director, Financial Markets and Community Investment. Oct 24, 2001
• Anthrax Vaccine: Changes to the Manufacturing Process (PDF) Statement of Nancy Kingsbury, Ph.D., Managing Director, Applied Research and Methods. Oct 23, 2001
• Combating Terrorism: Considerations for Investing Resources in Chemical and Biological Preparedness (PDF) Oct 17, 2001
• Bioterrorism: Review of Public Health Preparedness Programs (PDF) Statement by Janet Heinrich, Director, Health Care - Public Health Issues. Oct 10, 2001
• Food Safety and Security: Fundamental Changes Needed to Ensure Safe Food (PDF) Statement by Robert A. Robinson, Managing Director, Natural Resources and Environment. Covers bioterrorism and deliberate acts of food contamination. Oct 10, 2001
• Bioterrorism: Federal Research and Preparedness Activities (PDF) Sep 28, 2001
• Combating Terrorism: Comments on H.R. 525 to Create a President's Council on Domestic Terrorism Preparedness May 9, 2001
• Combating Terrorism: Accountability Over Medical Supplies Needs Further Improvement May 1, 2001
• Combating Terrorism: Observations on Options to Improve the Federal Response Apr 24, 2001
• Combating Terrorism: Comments on Counterterrorism Leadership and National Strategy Mar 27, 2001
• Combating Terrorism: FEMA Continues to Make Progress in Coordinating Preparedness and Response Mar 20, 2001
  
  Hoover Institution:
• International Relations: The Next Threat Covers the world's rogue nations. By Thomas H. Henriksen. From Hoover Digest, 2001, No. 3.
• Covert Operations, Now More Than Ever Discusses the use of covert operations as a less costly, more humane, and more effective form of warfare. By Thomas H. Henriksen. From Hoover Digest, 2000, No. 2.
• Ulterior Motives in Chechnya Discusses how the Russian military campaign in Chechnya has moved beyond the earlier limited objective of combating terrorism. By Michael McFaul. Dec 13, 1999
• The Administration Gets It Half Right Explains what's right and wrong with the administration's latest antiterrorism proposal. By Abraham D. Sofaer. From Hoover Digest, 1999, No. 3.
• Why We're Allowed to Hit Back Discusses the legal basis for attacks on terrorists. By Abraham D. Sofaer. From Hoover Digest, 1999, No. 2.
• Five Ways to Beat the Thugs Discusses steps we must take to counter the terrorist threat. By Abraham D. Sofaer. From Hoover Digest, 1999, No. 1.
• Triple Threat From a discussion with William J. Perry and George P. Schultz on security concerns involving Russia, China and terrorism. Interview by Peter Robinson. From Hoover Digest, 1998, No. 3.
• Preventive Defense Covers the dangers of the 21st century, including the threat of catastrophic terrorism. By William J. Perry and Ashton B. Carter. From Hoover Digest, 1999, No. 4.
• Using Power and Diplomacy to Deal with Rogue States By Thomas H. Henriksen. From Essays in Public Policy.
  
  Johns Hopkins University:
• Aftermath of a Hypothetical Smallpox Disaster By Jason Bardi. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
• Anthrax: A Possible Case History By Thomas V. Inglesby, Assistant Professor, School of Medicine. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
• Applying Lessons Learned from Anthrax Case History to Other Scenarios By John G. Bartlett, Professor, School of Medicine. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
• Nuclear Blindness: An Overview of the Biological Weapons Programs of the Former Soviet Union and Iraq By Christopher J. Davis, Consultant, Center for Civilian Biodefense Studies. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
• Smallpox: An Attack Scenario By Tara O'Toole, Senior Fellow, Center for Civilian Biodefense Studies. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
• Smallpox: Clinical and Epidemiologic Features By D. A. Henderson, Professor, Center for Civilian Biodefense Studies. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
• Vaccines in Civilian Defense Against Bioterrorism By Philip K. Russell, Professor, School of Public Health. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
  
  Monterey Institute of International Studies:
• Historical Trends Related to Bioterrorism: An Empirical Analysis By Jonathan B. Tucker, Director, Chemical and Biological Weapons Nonproliferation Project, Center for Nonproliferation Studies. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
  
  National Commission on Terrorism:
• Countering the Changing Threat of International Terrorism Covers the international terrorism threat, the use of intelligence, strategies against terrorism, and prevention and responses to catastrophic terrorist attacks. (PDF)
  
  National Security Council:
• Finding the Right Balance Against Bioterrorism By Richard A. Clarke, National Coordinatory for Security, Infrastructure Protection and Counter-Terrorism. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999. Nebraska Health and Human Services System:
• Anthrax (Bacillus anthracis) Fact Sheet
  
  New York State Department of Health
• Communicable Disease Fact Sheets: Anthrax
  
  Potomac Institute for Policy Studies:
• The Threat of Biological Attack: Why Concern Now? By David W. Siegrist, Research Fellow. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
  
  Research Planning, Inc.:
• Aum Shinrikyo: Once and Future Threat? By Kyle B. Olson. From Emerging Infectious Diseases, Vol. 5, No. 4. Jul - Aug 1999.
  
  Senate Committee on Commerce, Science, and Transportation (Science, Technology & Space Subcommittee Hearing):
• Dr. Lisa A. Simpson, Deputy Director, Agency for Health Care Research & Quality, Department of Health and Human Services, "Fighting Bioterrorism: The HHS Role in Using America's Scientists and Entrepreneurs to Find Solutions" Bioterrorism -- Science, Technology & Space Subcommittee Hearing, Senate Committee on Commerce, Science, and Transportation (Feb. 5, 2002)
• Statement of Dr. Anna Johnson-Winegar, Ph.D., Deputy Assistant Secretary of Defense for Chemical-Biological Defense Programs Bioterrorism -- Science, Technology & Space Subcommittee Hearing, Senate Committee on Commerce, Science, and Transportation (Feb. 5, 2002)
  
  South Dakota Department of Health:
• What is Anthrax?
  
  RAND Corporation:
• Op-Ed: Terrorist Trials Serve U.S. Strategy By Brian Michael Jenkins. Jan 7, 2001.
• Second Annual Report of the Advisory Panel to Assess Domestic Response Capabilities for Terrorism Involving Weapons of Mass Destruction Dec 14, 2000
• Taking Charge: A Bipartisan Report to the President Elect on Foreign Policy and National Security Edited by Frank Carlucci, Robert Hunter, Zalmay Khalilzad. © 2000
  • Presidential Transition Team Issues: Terrorism (PDF) By Bruce Hoffman.
• First Annual Report to the President and the Congress of the Advisory Panel to Assess Domestic Response Capabilities for Terrorism Involving Weapons of Mass Destruction (PDF) Dec 15, 1999
• Countering the New Terrorism By Ian O. Lesser, Bruce Hoffman, John Arquilla, David F. Ronfeldt, Michele Zanini and Brian Michael Jenkins. © 1999
  • Terrorism Trends and Prospects (PDF) By Bruce Hoffman.
  • Networks, Netwar, and Information-Age Terrorism (PDF) By John Arquilla, David Ronfeldt, and Michele Zanini.
  • Countering the New Terrorism: Implications for Strategy (PDF) By Ian O. Lesser.
• Rand Review, Vol. 22, No. 2, Winter 1998-99 Includes “Old Madness, New Methods: Revival of Religious Terrorism Begs For Broader U.S. Policy” by Bruce Hoffman.
  
  United Nations:
• Security Council Resolution 1189 on International Terrorism Aug 13, 1989